TY - JOUR
T1 - Cardiac rehabilitation availability and delivery in Europe
T2 - How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology
AU - Abreu, Ana
AU - Pesah, Ella
AU - Supervia, Marta
AU - Turk-Adawi, Karam
AU - Bjarnason-Wehrens, Birna
AU - Lopez-Jimenez, Francisco
AU - Ambrosetti, Marco
AU - Andersen, Karl
AU - Giga, Vojislav
AU - Vulic, Dusko
AU - Vataman, Eleonora
AU - Gaita, Dan
AU - Cliff, Jacqueline
AU - Kouidi, Evangelia
AU - Yagci, Ilker
AU - Simon, Attila
AU - Hautala, Arto
AU - Tamuleviciute-Prasciene, Egle
AU - Kemps, Hareld
AU - Eysymontt, Zbigniew
AU - Farsky, Stefan
AU - Hayward, Jo
AU - Prescott, Eva
AU - Dawkes, Susan
AU - Pavy, Bruno
AU - Kiessling, Anna
AU - Sovova, Eliska
AU - Grace, Sherry L.
N1 - Funding Information:
This work was performed at York University, Canada and Mayo Clinic, USA. On behalf of the International Council of Cardiovascular Prevention and Rehabilitation through which this study was undertaken, we are grateful to others who collaborated with us to identify and reach programmes in their European country, namely: Dr Alexander Aleksiev, Dr Josef Niebauer, Dr Borut Jug, Dr Henrik Schirmer, Dr Charles Delagardelle and Mr Ricky Thomas. We also thank the following associations for assisting with programme identification: the British Association of Cardiovascular Prevention and Rehabilitation, European Association of Preventive Cardiology (Secondary Prevention and Rehabilitation Section), the International Society of Physical Medicine and Rehabilitation and World Heart Federation (who also formally endorsed the study protocol).
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this work was supported by a minor research grant provided by the York University Faculty of Health.
Publisher Copyright:
© The European Society of Cardiology 2019.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Aims: The aims of this study were to establish cardiac rehabilitation availability and density, as well as the nature of programmes, and to compare these by European region (geoscheme) and with other high-income countries. Methods: A survey was administered to cardiac rehabilitation programmes globally. Cardiac associations were engaged to facilitate programme identification. Density was computed using global burden of disease study ischaemic heart disease incidence estimates. Four high-income countries were selected for comparison (N = 790 programmes) to European data, and multilevel analyses were performed. Results: Cardiac rehabilitation was available in 40/44 (90.9%) European countries. Data were collected in 37 (94.8% country response rate). A total of 455/1538 (29.6% response rate) programme respondents initiated the survey. Programme volumes (median 300) were greatest in western European countries, but overall were higher than in other high-income countries (P < 0.001). Across all Europe, there was on average only 1 CR spot per 7 IHD patients, with an unmet regional need of 3,449,460 spots annually. Most programmes were funded by social security (n = 25, 59.5%; with significant regional variation, P < 0.001), but in 72 (16.0%) patients paid some or all of the programme costs (or ∼18.5% of the ∼€150.0/programme) out of pocket. Guideline-indicated conditions were accepted in 70% or more of programmes (lower for stable coronary disease), with no regional variation. Programmes had a multidisciplinary team of 6.5 ± 3.0 staff (number and type varied regionally; and European programmes had more staff than other high-income countries), offering 8.5 ± 1.5/10 core components (consistent with other high-income countries) over 24.8 ± 26.0 hours (regional differences, P < 0.05). Conclusion: European cardiac rehabilitation capacity must be augmented. Where available, services were consistent with guidelines, but varied regionally.
AB - Aims: The aims of this study were to establish cardiac rehabilitation availability and density, as well as the nature of programmes, and to compare these by European region (geoscheme) and with other high-income countries. Methods: A survey was administered to cardiac rehabilitation programmes globally. Cardiac associations were engaged to facilitate programme identification. Density was computed using global burden of disease study ischaemic heart disease incidence estimates. Four high-income countries were selected for comparison (N = 790 programmes) to European data, and multilevel analyses were performed. Results: Cardiac rehabilitation was available in 40/44 (90.9%) European countries. Data were collected in 37 (94.8% country response rate). A total of 455/1538 (29.6% response rate) programme respondents initiated the survey. Programme volumes (median 300) were greatest in western European countries, but overall were higher than in other high-income countries (P < 0.001). Across all Europe, there was on average only 1 CR spot per 7 IHD patients, with an unmet regional need of 3,449,460 spots annually. Most programmes were funded by social security (n = 25, 59.5%; with significant regional variation, P < 0.001), but in 72 (16.0%) patients paid some or all of the programme costs (or ∼18.5% of the ∼€150.0/programme) out of pocket. Guideline-indicated conditions were accepted in 70% or more of programmes (lower for stable coronary disease), with no regional variation. Programmes had a multidisciplinary team of 6.5 ± 3.0 staff (number and type varied regionally; and European programmes had more staff than other high-income countries), offering 8.5 ± 1.5/10 core components (consistent with other high-income countries) over 24.8 ± 26.0 hours (regional differences, P < 0.05). Conclusion: European cardiac rehabilitation capacity must be augmented. Where available, services were consistent with guidelines, but varied regionally.
KW - Cardiac rehabilitation
KW - Europe
KW - survey
UR - http://www.scopus.com/inward/record.url?scp=85062044729&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062044729&partnerID=8YFLogxK
U2 - 10.1177/2047487319827453
DO - 10.1177/2047487319827453
M3 - Article
C2 - 30782007
AN - SCOPUS:85062044729
SN - 2047-4873
VL - 26
SP - 1131
EP - 1146
JO - European Journal of Preventive Cardiology
JF - European Journal of Preventive Cardiology
IS - 11
ER -